Xeljanz Effective in Ulcerative Colitis

Xeljanz (tofacitinib) is currently approved by the U. S. Food and Drug Administration (FDA), for use in the treatment of [...]

FDA Approves Renflexis as Biosimilar to Remicade

The U.S. Food and Drug Administration (FDA) has approved a biosimilar copy of Johnson & Johnson's rheumatoid arthritis drug Remicade [...]

To Cleanse or Not to Cleanse?

Wondering if you should jump on the bandwagon and commit to a dietary “cleanse” or “detox” regimen? Nutrition experts weigh [...]

Inflammatory Bowel Disease and Cancer Risk

Better screening and modern IBD treatments are improving the odds. By Sharon Reynolds A woman newly diagnosed with inflammatory bowel [...]

The Comfort of Good Care

Prioritizing your needs—both practical and emotional—and spending some time engaged in high-quality research will help you find the right physician. [...]

Tumor Necrosis Factor-alpha Inhibitor-Induced Psoriasis in Crohn’s Disease

Tumor necrosis factor-alpha (TNF) is a protein produced by immune cells to signal other immune cells to produce inflammatory factors. [...]

Anti-IL-23 Therapy A New Approach to Crohn's Disease

Doctors have reported the results of a novel targeted therapy that may represent a new treatment option for individuals with [...]

A Quick Primer on Crohn’s Disease

Crohn’s disease is an idiopathic, chronic, inflammatory process that can affect any part of the gastrointestinal (GI) tract from the [...]

Study Suggests Up to 75% of Irritable Bowel Syndrome Patients Undiagnosed

A report published by researchers in The American Journal of Gastroenterology by doctors from Washington University in Saint Louis and the David [...]


7 Facts You Need to Know about Colonoscopy

Screening is crucial for the prevention and early detection of colorectal cancer. The American Cancer Society currently recommends that people [...]

Colorectal Cancer Risk & Screening Recommendations

When it comes to colorectal cancer, screening is prevention. Colorectal cancer is no joke. Just get screened.  What’s Your Risk? Average [...]

« More News Tips & Features